Bragar Eagel & Squire, P.C. Is Investigating Loyalty Ventures, Inotiv, TG Therapeutics, and Allianz and Encourages Investors to Contact the Firm
24 juin 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Loyalty Ventures, Inc....
Bragar Eagel & Squire, P.C. Is Investigating Inotiv, TG Therapeutics, Singularity Future, and Allianz and Encourages Investors to Contact the Firm
19 juin 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, June 19, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Inotiv, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Kohl’s, MEI Pharma, and TG Therapeutics and Encourages Investors to Contact the Firm
13 juin 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Kohl’s Corporation (NYSE:...
Bragar Eagel & Squire, P.C. Is Investigating Medallion, RBB, Singularity Future, and TG Therapeutics and Encourages Investors to Contact the Firm
08 juin 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Medallion Financial Corp....
Bragar Eagel & Squire, P.C. Is Investigating TG Therapeutics, GoodRx, Agrify, and Pegasystems and Encourages Investors to Contact the Firm
03 juin 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, June 03, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TG Therapeutics, Inc....
Bragar Eagel & Squire, P.C. Is Investigating Clariant, TG Therapeutics, Coinbase, and GoodRx and Encourages Investors to Contact the Firm
22 mai 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 22, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Clariant AG (OTCMKTS:...
TG THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TG Therapeutics, Inc. on Behalf of TG Therapeutics Stockholders and Encourages Investors to Contact the Firm
27 déc. 2021 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against TG Therapeutics, Inc. (“TG...
TG THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TG Therapeutics, Inc. on Behalf of TG Therapeutics Stockholders and Encourages Investors to Contact the Firm
22 déc. 2021 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against TG Therapeutics, Inc. (“TG...
TG THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TG Therapeutics, Inc. on Behalf of TG Therapeutics Stockholders and Encourages Investors to Contact the Firm
02 déc. 2021 22h02 HE
|
Bragar Eagel & Squire
NEW YORK, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against TG Therapeutics, Inc. (“TG...
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against TG Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
03 déc. 2018 10h09 HE
|
Schall Law
LOS ANGELES, Dec. 03, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against TG Therapeutics, Inc. (“TG...